257 related articles for article (PubMed ID: 29804529)
1. Therapeutic Potential of Small Activating RNAs (saRNAs) in Human Cancers.
Yoon S; Rossi JJ
Curr Pharm Biotechnol; 2018; 19(8):604-610. PubMed ID: 29804529
[TBL] [Abstract][Full Text] [Related]
2. Current Advances in Small Activating RNAs for Gene Therapy: Principles, Applications and Challenges.
Zhou LY; He ZY; Xu T; Wei YQ
Curr Gene Ther; 2018; 18(3):134-142. PubMed ID: 29921205
[TBL] [Abstract][Full Text] [Related]
3. RNA Therapeutics for Treatment of Cardiovascular Diseases: Promises and Challenges.
Lucas T; Dimmeler S
Circ Res; 2016 Sep; 119(7):794-7. PubMed ID: 27635083
[No Abstract] [Full Text] [Related]
4. Mechanisms involved in the activation of C/EBPα by small activating RNA in hepatocellular carcinoma.
Zhao X; Reebye V; Hitchen P; Fan J; Jiang H; Sætrom P; Rossi J; Habib NA; Huang KW
Oncogene; 2019 May; 38(18):3446-3457. PubMed ID: 30643190
[TBL] [Abstract][Full Text] [Related]
5. Development of MTL-CEBPA: Small Activating RNA Drug for Hepatocellular Carcinoma.
Setten RL; Lightfoot HL; Habib NA; Rossi JJ
Curr Pharm Biotechnol; 2018; 19(8):611-621. PubMed ID: 29886828
[TBL] [Abstract][Full Text] [Related]
6. Oncogene dependency and the potential of targeted RNAi-based anti-cancer therapy.
Yan R; Hallam A; Stockley PG; Boyes J
Biochem J; 2014 Jul; 461(1):1-13. PubMed ID: 24927119
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic potential of RNAi in metabolic diseases.
Rondinone CM
Biotechniques; 2006 Apr; Suppl():31-6. PubMed ID: 16629385
[TBL] [Abstract][Full Text] [Related]
8. Running interference: prospects and obstacles to using small interfering RNAs as small molecule drugs.
Dykxhoorn DM; Lieberman J
Annu Rev Biomed Eng; 2006; 8():377-402. PubMed ID: 16834561
[TBL] [Abstract][Full Text] [Related]
9. Small interfering RNA-based molecular therapy of cancers.
Guo W; Chen W; Yu W; Huang W; Deng W
Chin J Cancer; 2013 Sep; 32(9):488-93. PubMed ID: 23327796
[TBL] [Abstract][Full Text] [Related]
10. The Therapeutic Potential of Small Activating RNAs for Colorectal Carcinoma.
Zheng B; Mai Q; Jiang J; Zhou Q
Curr Gene Ther; 2019; 19(3):140-146. PubMed ID: 31284860
[TBL] [Abstract][Full Text] [Related]
11. Enhancing DPYSL3 gene expression via a promoter-targeted small activating RNA approach suppresses cancer cell motility and metastasis.
Li C; Jiang W; Hu Q; Li LC; Dong L; Chen R; Zhang Y; Tang Y; Thrasher JB; Liu CB; Li B
Oncotarget; 2016 Apr; 7(16):22893-910. PubMed ID: 27014974
[TBL] [Abstract][Full Text] [Related]
12. Oncogene suppression by small interfering RNAs.
Heidenreich O
Curr Pharm Biotechnol; 2004 Aug; 5(4):349-54. PubMed ID: 15320765
[TBL] [Abstract][Full Text] [Related]
13. An update on RNA interference-mediated gene silencing in cancer therapy.
Ren YJ; Zhang Y
Expert Opin Biol Ther; 2014 Nov; 14(11):1581-92. PubMed ID: 25010067
[TBL] [Abstract][Full Text] [Related]
14. RNA interference: a potential therapeutic tool for silencing splice isoforms linked to human diseases.
Gaur RK
Biotechniques; 2006 Apr; Suppl():15-22. PubMed ID: 16629383
[TBL] [Abstract][Full Text] [Related]
15. Development and Mechanism of Small Activating RNA Targeting CEBPA, a Novel Therapeutic in Clinical Trials for Liver Cancer.
Voutila J; Reebye V; Roberts TC; Protopapa P; Andrikakou P; Blakey DC; Habib R; Huber H; Saetrom P; Rossi JJ; Habib NA
Mol Ther; 2017 Dec; 25(12):2705-2714. PubMed ID: 28882451
[TBL] [Abstract][Full Text] [Related]
16. saRNAdb: Resource of Small Activating RNAs for Up-regulating the Gene Expression.
Dar SA; Kumar M
J Mol Biol; 2018 Jul; 430(15):2212-2218. PubMed ID: 29625201
[TBL] [Abstract][Full Text] [Related]
17. The diversity of RNAi and its applications.
Gaur RK; Rossi JJ
Biotechniques; 2006 Apr; Suppl():4-5. PubMed ID: 16629381
[No Abstract] [Full Text] [Related]
18. Emerging RNA-based drugs: siRNAs, microRNAs and derivates.
Pereira TC; Lopes-Cendes I
Cent Nerv Syst Agents Med Chem; 2012 Sep; 12(3):217-32. PubMed ID: 22697266
[TBL] [Abstract][Full Text] [Related]
19. Emerging Progress of RNA-Based Antitumor Therapeutics.
Fu J; Dong H; Wu J; Jin Y
Int J Biol Sci; 2023; 19(10):3159-3183. PubMed ID: 37416764
[TBL] [Abstract][Full Text] [Related]
20. Short interfering RNA therapeutics: nanocarriers, prospects and limitations.
Mehrotra N; Tripathi RM
IET Nanobiotechnol; 2015 Dec; 9(6):386-95. PubMed ID: 26647816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
